People older than 65 and women are more likely to develop localized scleroderma, a study in the U.S. shows.The…
Articles by Andrea Lobo, PhD
Women have a nearly fivefold higher risk of developing systemic sclerosis (SSc), according to the findings of a nationwide…
A Phase 1/2 trial testing Cabaletta Bio’s CAR T-cell therapy, rese-cel (resecabtagene autoleucel), in adults with hard-to-treat systemic…
Treatment with Ofev (nintedanib) for up to four years was associated with a sustained slowing of lung function decline…
Low levels of a type of white blood cell called natural killer (NK) cells may help diagnose pulmonary arterial…
Autotaxin, a protein involved in wound healing and scarring, or fibrosis, was found at higher levels in women with…
Zura Bio has launched a Phase 2 trial to evaluate the safety and efficacy of tibulizumab, its experimental dual…
Fatigue levels in people with scleroderma, also known as systemic sclerosis or SSc, are tied to several social, demographic,…
The specific self-reactive antibodies (autoantibodies) of people with systemic sclerosis (SSc) overlap syndrome — a condition in which SSc…
The Scleroderma Research Foundation (SRF) has announced the star-studded lineup for its annual Cool Comedy, Hot Cuisine fundraising…